400
Participants
Start Date
March 7, 2024
Primary Completion Date
February 28, 2028
Study Completion Date
February 28, 2028
Resting State Functional Magnetic Resonance Imaging (rs-fMRI)
rs-fMRI + neurological and neuropsychological evaluation at preoperative timepoint and 1-2 months postop, 3-4 months postop, 6-8 months postop, 12 months postop
Up-front Motor Rehabilitation
personalized motor rehabilitation for 6 months + rs-fMRI + neurological and neuropsychological evaluation before starting motor rehabilitation, at 2-3 months during rehabilitation, 6-9 months during rehabilitation, before surgery (if surgery indicated by tumour board), 1 month postop, 2-3 months postop
Up-front Chemotherapy
Temozolomide at either 6 cycles consisting of 150-200 mg per square meter for 5 days during each 28-day cycle, or metronomic schedule, + rs-fMRI + neurological and neuropsychological evaluation before starting motor rehabilitation, at 2-3 months during rehabilitation, 6-9 months during rehabilitation, before surgery (if surgery indicated by tumour board), 1 month postop, 2-3 months Post
RECRUITING
IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan
University of Turin, Italy
OTHER
University of Milan
OTHER